Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
Background: Gastro-oesophageal reflux is prevalent in preterm infants. Despite widespread use in clinical practice, there is still much controversy over the efficacy and safety of drug interventions, particularly antacid therapy. Objective: To systematically review the effects of antacid therapy on preterm infants with symptoms of gastrooesophageal reflux, and to assess the safety of these interventions. Methods: We carried out an electronic search of the Cochrane central register of controlled trials (CENTRAL, The Cochrane Library), MEDLINE (1966-present), EMBASE (1980-present) and CINAHL (1982-present) as well as other online sources. Participants were preterm infants (<37 weeks gestation) with gastro-oesophageal reflux disease who were receiving care on a neonatal unit. We assessed the effects of histamine-2 receptor antagonists, proton pump inhibitors and alginates against placebo, primarily to see if they reduced the symptoms of reflux. results Six studies were included in this review. Meta-analysis could not be carried out due to a lack of studies assessing the same intervention with the same outcomes. Omeprazole therapy significantly reduced the oesophageal acid exposure percentage time with pH<4 (p<0.01) and sodium alginate significantly decreased gastrooesophageal reflux episodes (p=0.024). Metoclopramide and ranitidine showed a significant increase in gastrooesophageal reflux disease symptoms versus placebo (p<0.04). No significant results were found for the use of esomeprazole or lansoprazole versus placebo. Conclusions There is insufficient evidence available to conclude whether antacid therapy is effective or safe when treating gastro-oesophageal reflux disease in preterm infants. Further research is needed into this topic and caution should be taken when administering antacids to preterm infants.
Dermyshi, Elda
c5d231f4-da78-4f45-b58c-d223b34c75d6
Mackie, Charley
18952a41-6165-4aaf-9ef2-ecd14dd2a244
Kigozi, Phoebe
f6345321-22fc-471a-b89a-674151b9d96e
Schoonakker, Bernard
47adf186-a232-4bd6-9d5e-f687a1bab143
Dorling, Jon
e55dcb9a-a798-41a1-8753-9e9ff8aab630
January 2018
Dermyshi, Elda
c5d231f4-da78-4f45-b58c-d223b34c75d6
Mackie, Charley
18952a41-6165-4aaf-9ef2-ecd14dd2a244
Kigozi, Phoebe
f6345321-22fc-471a-b89a-674151b9d96e
Schoonakker, Bernard
47adf186-a232-4bd6-9d5e-f687a1bab143
Dorling, Jon
e55dcb9a-a798-41a1-8753-9e9ff8aab630
Dermyshi, Elda, Mackie, Charley, Kigozi, Phoebe, Schoonakker, Bernard and Dorling, Jon
(2018)
Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review.
BMJ Paediatrics Open, 2 (1), [e000287].
(doi:10.1136/bmjpo-2018-000287).
Abstract
Background: Gastro-oesophageal reflux is prevalent in preterm infants. Despite widespread use in clinical practice, there is still much controversy over the efficacy and safety of drug interventions, particularly antacid therapy. Objective: To systematically review the effects of antacid therapy on preterm infants with symptoms of gastrooesophageal reflux, and to assess the safety of these interventions. Methods: We carried out an electronic search of the Cochrane central register of controlled trials (CENTRAL, The Cochrane Library), MEDLINE (1966-present), EMBASE (1980-present) and CINAHL (1982-present) as well as other online sources. Participants were preterm infants (<37 weeks gestation) with gastro-oesophageal reflux disease who were receiving care on a neonatal unit. We assessed the effects of histamine-2 receptor antagonists, proton pump inhibitors and alginates against placebo, primarily to see if they reduced the symptoms of reflux. results Six studies were included in this review. Meta-analysis could not be carried out due to a lack of studies assessing the same intervention with the same outcomes. Omeprazole therapy significantly reduced the oesophageal acid exposure percentage time with pH<4 (p<0.01) and sodium alginate significantly decreased gastrooesophageal reflux episodes (p=0.024). Metoclopramide and ranitidine showed a significant increase in gastrooesophageal reflux disease symptoms versus placebo (p<0.04). No significant results were found for the use of esomeprazole or lansoprazole versus placebo. Conclusions There is insufficient evidence available to conclude whether antacid therapy is effective or safe when treating gastro-oesophageal reflux disease in preterm infants. Further research is needed into this topic and caution should be taken when administering antacids to preterm infants.
This record has no associated files available for download.
More information
Published date: January 2018
Additional Information:
Publisher Copyright:
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved.
Identifiers
Local EPrints ID: 485069
URI: http://eprints.soton.ac.uk/id/eprint/485069
PURE UUID: 46a5d864-107d-40ef-a58c-9b32cdb2000c
Catalogue record
Date deposited: 28 Nov 2023 18:06
Last modified: 18 Mar 2024 04:16
Export record
Altmetrics
Contributors
Author:
Elda Dermyshi
Author:
Charley Mackie
Author:
Phoebe Kigozi
Author:
Bernard Schoonakker
Author:
Jon Dorling
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics